Questionnaire survey on participation in treatment for general consumers
Not Applicable
- Conditions
- Glaucoma
- Registration Number
- JPRN-UMIN000040829
- Lead Sponsor
- Santen Pharmaceutical Co., Ltd.
- Brief Summary
More than 70 percent of the subjects answered that they would like to be involved in drug selection when they are diagnosed with glaucoma for the first time and decide on a treatment, and they indicated higher treatment compliance and intention to continue hospital visits when they involved in drug selection. From these facts, it is considered desirable for patients to be involved in the drug selection in in order to improving adherence.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 108
Inclusion Criteria
Not provided
Exclusion Criteria
Those who previously diagnosed with glaucoma Those who have relatives diagnosed with glaucoma Medical professionals (doctors, pharmacists, nurses, etc.) Those engaged in the manufacturing of pharmaceuticals and medical products Person engaged in drug marketing
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intention to participate in the selection of therapeutic agents Intention to adhere to instillation and continue visiting hospitals by participating in the selection of therapeutic agents
- Secondary Outcome Measures
Name Time Method